FCX vs XRAY · P/E 38, rev $25.45B vs rev $3.68B
Freeport-McMoran Copper & Gold Inc (FCX) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
Freeport-McMoran Copper & Gold Inc (FCX) is a copper company listed on US.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
Latest reported FCX revenue for 2024-12-31 was $25.45B. Net income was $4.40B. Revenue was up 11.4% from 2023-12-31 to 2024-12-31. FCX currently screens at market cap $67.80B and trailing P/E 38.0.
Latest reported XRAY revenue for 2025-12-31 was $3.68B. Net income was -$598.0M. Revenue was down 3.0% from 2024-12-31 to 2025-12-31. XRAY currently screens at market cap $2.01B.
FCX currently screens at market cap $67.80B and trailing P/E 38.0. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the FCX and XRAY stock pages for the full models.
Not investment advice.